IMMUNOLOGY FOUNDATIONS
Immunology Foundations
Immunology becomes easier to understand when the cells, antibodies, complement proteins, and cytokines are viewed as parts of one coordinated response. This guide reviews the normal immune process so that immune deficiencies, hypersensitivity reactions, infections, and inflammatory disorders can be traced back to the component that is absent, excessive, or misdirected.
The big picture: Innate immunity detects danger and begins the response. Antigen-presenting cells connect that response to adaptive immunity. T cells coordinate or carry out cellular defense, B cells produce antibodies, complement amplifies clearance, and regulatory mechanisms limit damage after the threat is controlled (Kishiyama et al., 2019; Norris, 2020).
Skip ahead:
The Immune Response as a Sequence
The normal immune response can be organized into five overlapping phases (Kishiyama et al., 2019; Norris, 2020):
- Prevention and recognition: Physical and chemical barriers limit entry. Sentinel cells recognize microbial patterns or signs of tissue injury when a barrier is breached.
- Innate containment: Cytokines activate local endothelium, chemokines recruit leukocytes, phagocytes ingest targets, and complement amplifies inflammation and clearance.
- Antigen presentation: Dendritic cells and other antigen-presenting cells process antigen and display it to T lymphocytes in lymphoid tissue.
- Adaptive effector response: CD4 helper T cells coordinate the response, CD8 cytotoxic T cells kill selected target cells, and activated B cells become antibody-secreting plasma cells.
- Resolution and memory: Regulatory mechanisms limit continuing tissue injury, while memory B and T cells prepare the host for a faster response after future exposure.
Innate and Adaptive Immunity
Innate immunity
Innate immunity is present before a specific exposure and responds rapidly. It recognizes broad patterns rather than one unique antigen. Its major components include epithelial barriers, phagocytes, dendritic cells, natural killer cells, mast cells, soluble mediators, acute-phase proteins, and complement. Innate immunity contains an infection while also shaping the adaptive response that follows (Kishiyama et al., 2019).
Adaptive immunity
Adaptive immunity is antigen-specific and produces memory. The first response requires lymphocyte activation and clonal expansion, so it develops more slowly. Re-exposure produces a faster and stronger response because memory cells and circulating antibodies are already present. Adaptive immunity has two interacting arms: humoral immunity, mediated by B cells and antibodies, and cell-mediated immunity, carried out primarily by T lymphocytes (Kishiyama et al., 2019; Norris, 2020).
Immune Cell Quick Reference
| Cell | High-yield role |
|---|---|
| Neutrophil | Rapidly recruited phagocyte that ingests and kills microbes during acute inflammation. |
| Macrophage | Recognizes and phagocytoses microbes and debris, releases inflammatory cytokines, presents antigen, and participates in repair. |
| Dendritic cell | Captures antigen in peripheral tissue, transports it to lymphoid tissue, and efficiently activates naive T cells. |
| Natural killer cell | Provides innate cytotoxic defense against infected or abnormal cells and can kill antibody-coated targets. |
| Mast cell and basophil | Release histamine and other mediators after IgE cross-linking or other activating signals. They are central to immediate hypersensitivity. |
| Eosinophil | Participates in defense against helminths and contributes to allergic inflammation. IL-5 is an important eosinophil growth and activation signal. |
| B cell and plasma cell | B cells recognize antigen, present antigen, and can become plasma cells that secrete antigen-specific antibody. |
| CD4 helper T cell | Coordinates immune responses through cell contact and cytokines that activate macrophages, assist B cells, and shape other effector responses. |
| CD8 cytotoxic T cell | Recognizes antigen presented with MHC I and kills selected infected, malignant, or foreign target cells. |
| Regulatory T cell | Suppresses excessive effector activity and helps maintain immune tolerance. |
Note. Cell functions are summarized from Kishiyama et al. (2019) and Norris (2020).
Antigen Presentation: The Bridge Between the Two Systems
Most protein antigens must be captured, processed into fragments, and displayed with a major histocompatibility complex molecule before a T cell can recognize them. Dendritic cells are especially effective at carrying antigen from tissues to lymphoid organs and initiating adaptive immunity. The key presentation pathways are summarized below (Kishiyama et al., 2019).
- MHC class I presents to CD8 T cells. Most nucleated cells express MHC I. This pathway allows CD8 cytotoxic T cells to detect intracellular abnormalities, including viral infection, and kill the affected cell.
- MHC class II presents to CD4 T cells. Professional antigen-presenting cells express MHC II. CD4 helper T cells respond by producing signals that activate macrophages, assist B cells, recruit other leukocytes, and support cytotoxic responses.
- Costimulation matters. Antigen recognition alone is not always enough. Accessory signals and the surrounding cytokine environment determine whether a lymphocyte activates, differentiates, becomes unresponsive, or undergoes apoptosis.
B Cells, Antibodies, and Immunoglobulin Classes
A B cell binds its specific antigen through a surface immunoglobulin receptor. With appropriate activation and T-cell support, it proliferates and differentiates into plasma cells that secrete antibody. Some activated B cells become memory cells. Antibodies act primarily through neutralization, prevention of microbial attachment, opsonization, complement activation, and recruitment of cellular effector mechanisms (Kishiyama et al., 2019; Norris, 2020).
| Immunoglobulin | High-yield function |
|---|---|
| IgM | First major antibody produced in a primary response. It is effective at agglutination and activation of the classical complement pathway. |
| IgG | Predominant antibody in the secondary response. It neutralizes and opsonizes; some IgG subclasses activate complement. IgG is the immunoglobulin class that crosses the placenta. |
| IgA | Protects mucosal surfaces and is present in secretions. It helps neutralize organisms and toxins before they invade tissue. |
| IgE | Binds mast cells and basophils. It is central to immediate allergic reactions and contributes to defense against helminths. |
| IgD | Functions mainly as a surface receptor on mature naive B cells together with IgM. |
Note. Immunoglobulin functions are summarized from Kishiyama et al. (2019) and Norris (2020).
Complement: Three Pathways, One Common Cascade
Complement is a family of circulating proteins that are activated in sequence. The three pathways begin differently but converge at C3. From that point, the cascade supports inflammation, opsonization, phagocytosis, and terminal membrane injury (Kishiyama et al., 2019; Norris, 2020).
- Classical pathway: Begins when C1q binds exposed Fc regions of antigen-bound IgM or IgG. This pathway connects adaptive antibody recognition to innate effector activity.
- Lectin pathway: Begins when mannose-binding lectin recognizes carbohydrate patterns on a microbial surface. It does not require antibody.
- Alternative pathway: Is activated on susceptible microbial surfaces without requiring an antigen-antibody complex or the early classical components C1, C4, and C2.
Follow the cascade
Although the initiating proteins differ, the functional sequence is similar (Kishiyama et al., 2019; Norris, 2020):
- Pathway activation produces a C3 convertase.
- C3 convertase cleaves C3 into C3a and C3b.
- C3b coats microbial surfaces for phagocytosis and participates in formation of a C5 convertase.
- C5 convertase cleaves C5 into C5a and C5b.
- C5b recruits C6 through C9 to assemble the membrane attack complex.
What the important complement fragments do
| Component | Primary role |
|---|---|
| C3b and C4b | Bind targets and improve recognition by phagocytes. C3b is the major complement opsonin and also helps continue the cascade. |
| C3a, C4a, and C5a | Promote inflammation and mast-cell or basophil mediator release. C5a is the most powerful leukocyte chemoattractant of the three. |
| C5b through C9 | Assemble the membrane attack complex, which forms pores and can lyse susceptible targets. |
| Complement regulators | Restrict activation on host tissues. Without effective regulation, the same cascade that protects the host can cause inflammation and tissue injury. |
Note. Complement pathways and fragment functions are summarized from Kishiyama et al. (2019) and Norris (2020).
Clinical connection: Defects affecting C3 impair opsonization and increase susceptibility to encapsulated bacteria. Deficiencies of C5 through C9 prevent effective membrane attack complex formation and are strongly associated with recurrent Neisseria infection. C1-inhibitor normally regulates both complement activation and the kallikrein-kinin system. Its deficiency allows excessive bradykinin activity and causes hereditary angioedema, which is not an IgE-mediated allergic reaction (Kishiyama et al., 2019; Norris, 2020).
Cytokines, Interleukins, and Chemokines
Cytokine is the broad term for a soluble signal released by cells to change the behavior of other cells. Interleukins are a subset of cytokines historically named for communication among leukocytes, although many are produced by and act on other cell types. Chemokines are cytokines specialized in directing cell movement. Their effects depend on the producing cell, target-cell receptors, timing, concentration, and the other signals present at the same time (Kishiyama et al., 2019; Norris, 2020).
| Signal | High-yield role |
|---|---|
| IL-1 and TNF | Major inflammatory signals from activated macrophages. They activate endothelium, promote leukocyte recruitment, and contribute to fever and systemic inflammatory effects. |
| IL-2 | Supports T-cell activation, proliferation, survival, and further cytokine production. |
| IL-4 and IL-13 | Promote a T-helper 2 pattern and support B-cell class switching to IgE. They are important in allergic disease and defense against helminths. |
| IL-5 | Promotes eosinophil growth, differentiation, recruitment, and activation. |
| IL-6 | Contributes to inflammation and the acute-phase response and supports B-cell differentiation. |
| IL-8 (CXCL8) | A chemokine that strongly recruits neutrophils to sites of acute inflammation. |
| IL-10 and TGF-β | Help suppress and regulate immune responses, supporting tolerance and limiting continued inflammation. |
| IL-12 | Promotes T-helper 1 development and supports interferon-γ production during responses to intracellular organisms. |
| IL-17 | Promotes early phagocytic defense by recruiting neutrophils to sites of infection and acute inflammation. |
| IFN-α and IFN-β | Support cellular resistance to viral infection. |
| IFN-γ | Activates macrophages and supports cell-mediated defense against intracellular organisms. |
Note. Cytokine functions are summarized from Kishiyama et al. (2019) and Norris (2020).
T-Helper Patterns Organize the Response
CD4 T-cell subsets develop in response to the antigen, antigen-presenting cell, costimulatory signals, and surrounding cytokine environment (Kishiyama et al., 2019):
- Th1: Develops in an IL-12-rich environment and produces IFN-γ and TNF. It strengthens macrophage killing and cell-mediated defense against intracellular organisms.
- Th2: Develops in the presence of IL-4 and produces IL-4, IL-5, and IL-13. It supports antibody responses, IgE production, eosinophils, defense against helminths, and allergic inflammation.
- Th17: Produces IL-17 and recruits neutrophils, particularly for early defense at skin and mucosal surfaces. Dysregulated Th17 activity can also contribute to inflammatory disease.
- Regulatory T cells: Suppress activated effector responses through mechanisms that include IL-10 and TGF-β. They help maintain tolerance and prevent an appropriate response from continuing unchecked.
Active and Passive Immunity
- Active immunity develops when the host responds to an antigen after infection or vaccination. The initial response takes time, but it produces memory B and T cells and is generally long lasting (Norris, 2020).
- Passive immunity results from transfer of preformed antibody. Examples include maternal IgG transferred across the placenta, IgA supplied through colostrum and breast milk, and administered immunoglobulin products. Protection is immediate but temporary because the recipient does not create memory from the transferred antibody alone (Norris, 2020).
How the Components Work Together: An Extracellular Bacterial Infection
This example applies the framework to a bacterium that crosses a mucosal barrier (Kishiyama et al., 2019; Norris, 2020):
- Macrophages and dendritic cells recognize microbial patterns and release inflammatory cytokines and chemokines.
- Local endothelium becomes more adhesive and permeable, allowing neutrophils and plasma proteins to enter the tissue.
- Complement activation generates inflammatory fragments and deposits C3b on the bacterium. Neutrophils and macrophages bind the opsonized target and phagocytose it.
- Dendritic cells carry processed antigen to lymphoid tissue and present it with MHC II to CD4 T cells.
- Helper T-cell signals support B-cell proliferation, class switching, and plasma-cell formation.
- Antibody neutralizes the organism, improves opsonization, and can activate the classical complement pathway.
- After clearance, regulatory signals reduce inflammation and memory lymphocytes remain.
When the System Is Missing, Excessive, or Misdirected
The pattern of illness often reflects the immune component that is affected (Kishiyama et al., 2019; Norris, 2020):
- Antibody deficiency reduces neutralization, opsonization, and classical complement activation, often producing recurrent sinopulmonary bacterial infections.
- T-cell deficiency weakens immune coordination and cell-mediated defense, increasing susceptibility to viral, fungal, intracellular bacterial, protozoal, and other opportunistic infections. Profound T-cell dysfunction also impairs effective antibody responses.
- Phagocyte dysfunction can allow microbes to be recognized and ingested but not effectively killed, as occurs with defective oxidative killing in chronic granulomatous disease.
- Complement deficiency produces different infection patterns depending on where the cascade is interrupted.
- Excessive or misdirected responses produce hypersensitivity, autoimmunity, chronic inflammation, or host-tissue injury.
The Four Hypersensitivity Patterns
| Type | Core mechanism |
|---|---|
| Type I | Immediate, IgE-mediated mast-cell and basophil activation. Examples include allergic rhinitis and anaphylaxis. |
| Type II | Antibody binds a cell or tissue target and causes destruction, inflammation, or altered receptor function. |
| Type III | Antigen-antibody complexes form in circulation, deposit in tissues, activate complement, and produce inflammation. |
| Type IV | Delayed, T-cell-mediated inflammation or cytotoxicity. Examples include allergic contact dermatitis and tuberculin reactions. |
Note. Hypersensitivity mechanisms are summarized from Kishiyama et al. (2019) and Norris (2020).
A Clinical Reasoning Framework
When reviewing an immune-mediated condition, ask:
- Is the primary problem in innate immunity, humoral immunity, cell-mediated immunity, or immune regulation?
- Is the response deficient, excessive, or directed against the wrong target?
- Is recognition, recruitment, opsonization, ingestion, intracellular killing, antibody production, or regulation failing?
- Which organisms, exposures, tissues, or complications would that mechanism predict?
- Which laboratory findings would identify the affected component, such as immunoglobulin levels, lymphocyte subsets, complement testing, or phagocyte-function testing?
Related YourDNP Guides
This resource is intended for education and clinical-reasoning review. It does not replace patient-specific assessment, current clinical guidance, institutional protocols, or consultation with an appropriate clinician or specialist.
References
Kishiyama, J. L., Chang, J. J., & Donovan, S. M. (2019). Disorders of the immune system. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., pp. 29–64). McGraw-Hill Education.
Norris, T. L. (2020). Porth’s essentials of pathophysiology (5th ed.). Wolters Kluwer.